224 related articles for article (PubMed ID: 25339509)
1. Liver transplantation in patients with common variable immunodeficiency: a report of two cases.
Montalti R; Mocchegiani F; Vincenzi P; Svegliati Baroni G; Nicolini D; Vivarelli M
Ann Transplant; 2014 Oct; 19():541-4. PubMed ID: 25339509
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
[TBL] [Abstract][Full Text] [Related]
3. [Old donors in liver transplantation for chronic hepatitis C].
Aguilera V; Ponce M; Berenguer M; Moreno R; Rayón JM; Sanjuán F; Prieto M; Mir J
Rev Esp Enferm Dig; 2007 Oct; 99(10):581-7. PubMed ID: 18052661
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin blockade does not affect fibrosis progression in recurrent hepatitis C after liver transplantation.
Guillaud O; Gurram KC; Puglia M; Lilly L; Adeyi O; Renner EL; Selzner N
Transplant Proc; 2013; 45(6):2331-6. PubMed ID: 23953545
[TBL] [Abstract][Full Text] [Related]
5. The difference in the fibrosis progression of recurrent hepatitis C after live donor liver transplantation versus deceased donor liver transplantation is attributable to the difference in donor age.
Selzner N; Girgrah N; Lilly L; Guindi M; Selzner M; Therapondos G; Adeyi O; McGilvray I; Cattral M; Greig PD; Grant D; Levy G; Renner EL
Liver Transpl; 2008 Dec; 14(12):1778-86. PubMed ID: 19025914
[TBL] [Abstract][Full Text] [Related]
6. Liver transplantation for severe hepatitis in patients with common variable immunodeficiency.
Murakawa Y; Miyagawa-Hayashino A; Ogura Y; Egawa H; Okamoto S; Soejima Y; Kurosawa M; Sumiyoshi S; Uemoto S; Haga H
Pediatr Transplant; 2012 Sep; 16(6):E210-6. PubMed ID: 21831259
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of liver transplantation in simultaneously hepatitis B surface antigen and hepatitis C virus RNA positive recipients: the deleterious effect of donor hepatitis B core antibody positivity.
Tandoi F; Romagnoli R; Martini S; Mazza E; Nada E; Cocchis D; Lupo F; Salizzoni M
Transplant Proc; 2012 Sep; 44(7):1960-2. PubMed ID: 22974882
[TBL] [Abstract][Full Text] [Related]
8. University of Modena experience in HIV-positive patients undergoing liver transplantation.
Di Benedetto F; Tarantino G; De Ruvo N; Cautero N; Montalti R; Guerrini GP; Ballarin R; Spaggiari M; Smerieri N; Serra V; Rompianesi G; D'Amico G; Mimmo A; Iemmolo RM; Codeluppi M; Cocchi S; Guaraldi G; Gerunda GE
Transplant Proc; 2011 May; 43(4):1114-8. PubMed ID: 21620066
[TBL] [Abstract][Full Text] [Related]
9. Prophylaxis against hepatitis B virus recurrence after liver transplantation for hepatitis B virus-related end-stage liver diseases with severe hypersplenism and splenomegaly: role of splenectomy.
Zhang Y; Yan L; Wen T; Li B; Zhao J; Chen Z; Wang W; Xu M; Yang J; Wei Y; Ma Y; Jiang L
J Surg Res; 2012 Nov; 178(1):478-86. PubMed ID: 22483806
[TBL] [Abstract][Full Text] [Related]
10. Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases.
Duan BW; Lu SC; Wang ML; Liu JN; Chi P; Lai W; Wu JS; Guo QL; Lin DD; Liu Y; Zeng DB; Li CY; Meng QH; Ding HG; Chen XY; Liao HY; Ma LQ; Chen Y; Zhang J; Xiang HP; Duan ZP; Li N
J Surg Res; 2013 Aug; 183(2):936-43. PubMed ID: 23558257
[TBL] [Abstract][Full Text] [Related]
11. Simple prediction of long-term clinical outcomes in patients with mild hepatitis C recurrence after liver transplantation.
Gambato M; Crespo G; Torres F; LLovet L; Carrión J; Londoño M; Lens S; Mariño Z; Bartres C; Miquel R; Navasa M; Forns X
Transpl Int; 2016 Jun; 29(6):698-706. PubMed ID: 26661662
[TBL] [Abstract][Full Text] [Related]
12. Liver transplantation in the MELD era--analysis of the OPTN/UNOS registry.
Taniguchi M
Clin Transpl; 2012; ():41-65. PubMed ID: 23721009
[TBL] [Abstract][Full Text] [Related]
13. Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C.
Burak KW; Kremers WK; Batts KP; Wiesner RH; Rosen CB; Razonable RR; Paya CV; Charlton MR
Liver Transpl; 2002 Apr; 8(4):362-9. PubMed ID: 11965581
[TBL] [Abstract][Full Text] [Related]
14. Successful outcome of liver transplantation in a patient with hepatitis C and common variable immune deficiency.
Gow PJ; Mutimer D
Transpl Int; 2002 Jul; 15(7):380-3. PubMed ID: 12122517
[TBL] [Abstract][Full Text] [Related]
15. Aspergillosis after liver transplantation in the context of common variable immunodeficiency: case report.
Chen Y; Cameron A
Transpl Infect Dis; 2013 Oct; 15(5):540-4. PubMed ID: 23676145
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients.
Duclos-Vallée JC; Vittecoq D; Teicher E; Feray C; Roque-Afonso AM; Lombès A; Jardel C; Gigou M; Dussaix E; Sebagh M; Guettier C; Azoulay D; Adam R; Ichaï P; Saliba F; Roche B; Castaing D; Bismuth H; Samuel D
J Hepatol; 2005 Mar; 42(3):341-9. PubMed ID: 15710216
[TBL] [Abstract][Full Text] [Related]
17. Rapidly progressive recurrent hepatitis C virus infection starting 9 days after liver transplantation.
Saraf N; Fiel MI; Deboccardo G; Emre S; Schiano TD
Liver Transpl; 2007 Jun; 13(6):913-7. PubMed ID: 17539015
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of liver transplantation from hepatitis B core antibody-positive donors in viral cirrhosis patients: the prevailing negative effect of recipient hepatitis C virus infection.
Tandoi F; Romagnoli R; Martini S; Mazza E; Nada E; Cocchis D; Lupo F; Salizzoni M
Transplant Proc; 2012 Sep; 44(7):1963-5. PubMed ID: 22974883
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis viruses and liver transplantation: evolving trends in antiviral management.
Verna EC
Clin Liver Dis; 2014 Aug; 18(3):575-601. PubMed ID: 25017077
[TBL] [Abstract][Full Text] [Related]
20. Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes.
Burra P; Germani G; Adam R; Karam V; Marzano A; Lampertico P; Salizzoni M; Filipponi F; Klempnauer JL; Castaing D; Kilic M; Carlis LD; Neuhaus P; Yilmaz S; Paul A; Pinna AD; Burroughs AK; Russo FP
J Hepatol; 2013 Feb; 58(2):287-96. PubMed ID: 23099188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
